Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:26 pm Purchase | 2026-03-31 | 13G | LB PHARMACEUTICALS INC LBRX | TCG Crossover GP II, LLC | 1,839,489 6.400% | 94,474 (+5.41%) | Filing History |
| 2026-05-15 4:11 pm Purchase | 2026-03-31 | 13G | LB PHARMACEUTICALS INC LBRX | Commodore Capital LP | 1,972,369 6.800% | 747,369 (+61.01%) | Filing History |
| 2026-05-15 10:43 am Purchase | 2026-03-31 | 13G | LB PHARMACEUTICALS INC LBRX | Caligan Partners LP | 1,438,070 5.000% | 1,438,070 (New Position) | Filing History |
| 2026-05-13 10:53 am Sale | 2026-03-31 | 13G | LB PHARMACEUTICALS INC LBRX | JPMORGAN CHASE & CO JPM | 1,427,568 4.900% | -183,914 (-11.41%) | Filing History |
| 2026-02-17 4:35 pm Purchase | 2025-12-31 | 13G | LB PHARMACEUTICALS INC LBRX | RA Capital Management, L.P. | 2,208,604 8.700% | 533,604 (+31.86%) | Filing History |
| 2026-02-10 4:30 pm Unchanged | 2025-02-06 | 13D | LB PHARMACEUTICALS INC LBRX | Deep Track Capital, LP | 3,352,804 11.700% | 0 (Unchanged) | Filing History |
| 2026-01-21 12:30 pm Purchase | 2025-12-31 | 13G | LB PHARMACEUTICALS INC LBRX | BlackRock, Inc. BLK | 1,277,776 5.100% | 1,277,776 (New Position) | Filing History |
| 2026-01-21 12:26 pm Sale | 2025-12-31 | 13G | LB PHARMACEUTICALS INC LBRX | BlackRock Portfolio Management LLC | 961,158 3.800% | -13,842 (-1.42%) | Filing History |
| 2026-01-21 08:13 am Purchase | 2025-12-31 | 13G | LB PHARMACEUTICALS INC LBRX | JPMORGAN CHASE & CO JPM | 1,611,482 6.300% | 1,611,482 (New Position) | Filing History |
| 2025-12-31 5:00 pm Purchase | 2025-12-24 | 13G | LB PHARMACEUTICALS INC LBRX | Trails Edge Capital Partners, LP | 1,268,265 5.000% | 1,268,265 (New Position) | Filing History |
| 2025-10-17 12:45 pm Purchase | 2025-09-30 | 13G | LB PHARMACEUTICALS INC LBRX | BlackRock Portfolio Management LLC | 975,000 5.900% | 975,000 (New Position) | Filing History |
| 2025-09-25 10:55 am Purchase | 2025-09-12 | 13D | LB PHARMACEUTICALS INC LBRX | Pontifax VI G.P. L.P. | 1,411,681 6.300% | 1,411,681 (New Position) | Filing History |
| 2025-09-19 4:47 pm Purchase | 2025-09-12 | 13G | LB PHARMACEUTICALS INC LBRX | RA Capital Management, L.P. | 1,675,000 7.500% | 1,675,000 (New Position) | Filing History |
| 2025-09-19 4:30 pm Purchase | 2025-09-12 | 13D | LB PHARMACEUTICALS INC LBRX | Deep Track Capital, LP | 3,352,804 14.900% | 3,352,804 (New Position) | Filing History |
| 2025-09-18 4:24 pm Purchase | 2025-09-12 | 13G | LB PHARMACEUTICALS INC LBRX | TCG Crossover GP II, LLC | 1,745,015 7.800% | 1,745,015 (New Position) | Filing History |
| 2025-09-18 4:01 pm Purchase | 2025-09-11 | 13G | LB PHARMACEUTICALS INC LBRX | Commodore Capital LP | 1,225,000 5.500% | 1,225,000 (New Position) | Filing History |